Reação de hipersensibilidade atípica à injeção de toxina botulínica
DOI:
https://doi.org/10.48208/HeadacheMed.2023.21Palavras-chave:
Botox, Anafilaxia, Efeitos colaterais e reações adversas relacionados a medicamentos, Dor de cabeça crônicaResumo
A injeção de toxina botulínica tipo A (BTA), comercializada como BOTOX, é comumente usada como tratamento para uma variedade de indicações clínicas e é amplamente considerada segura, eficaz e amplamente desprovida de efeitos colaterais graves. As reações anafiláticas ao BTA são tipicamente inéditas na literatura científica. BOTOX é aprovado pela Food and Drug Administration para o tratamento da distonia cervical e profilaxia para enxaquecas crônicas. Este relato de caso documenta um caso único de reação alérgica ao BTA em uma mulher de 29 anos com dor de cabeça cervicogênica e distonia cervical que relatou rubor imediato, tontura e náusea após receber injeções de BTA.
Downloads
Referências
Sjaastad O, Saunte C, Hovdahl H, Breivik H and Grønbâk E. “Cervicogenic” Headache. An Hypothesis. Cephalalgia 2016; 3(4): 249-256 Doi:10.1046/j.1468-2982.1983.0304249.x DOI: https://doi.org/10.1046/j.1468-2982.1983.0304249.x
Moore C, Diaz D and Kane A. Physical Therapy Management of Adults with Mild Traumatic Brain Injury. Seminars in Speech and Language 2019; 40(01): 036-047 Doi:10.1055/s-0038-1676652 DOI: https://doi.org/10.1055/s-0038-1676652
Wu B, Yue L, Sun F, Gao S, Liang B and Tao T. The Feasibility and Efficacy of Ultrasound-Guided C2 Nerve Root Coblation for Cervicogenic Headache. Pain Medicine 2019; 20(6): 1219-1226 Doi:10.1093/pm/pny227 DOI: https://doi.org/10.1093/pm/pny227
Moye LS, Tipton AF, Dripps I, Sheets Z, Crombie A, Violin JD and Pradhan AA. Delta opioid receptor agonists are effective for multiple types of headache disorders. Neuropharmacology 2019; 148(77-86 Doi:10.1016/j.neuropharm.2018.12.017 DOI: https://doi.org/10.1016/j.neuropharm.2018.12.017
Mares C, Dagher JH and Harissi-Dagher M. Narrative Review of the Pathophysiology of Headaches and Photosensitivity in Mild Traumatic Brain Injury and Concussion. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2018; 46(1): 14-22 Doi:10.1017/cjn.2018.361 DOI: https://doi.org/10.1017/cjn.2018.361
Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, . . . Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010; 30(7): 804-814 Doi:10.1177/0333102410364677 DOI: https://doi.org/10.1177/0333102410364677
Kumar R. Therapeutic use of botulinum toxin in pain treatment. Neuronal Signaling 2018; 2(3): Doi:10.1042/ns20180058 DOI: https://doi.org/10.1042/NS20180058
Wissel J, Müller J, Dressnandt J, Heinen F, Naumann M, Topka H and Poewe W. Management of Spasticity Associated Pain with Botulinum Toxin A. Journal of Pain and Symptom Management 2000; 20(1): 44-49 Doi:10.1016/s0885-3924(00)00146-9 DOI: https://doi.org/10.1016/S0885-3924(00)00146-9
Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA and Calne DB. Treatment of spasticity with botulinum toxin: A double-blind study. Annals of Neurology 1990; 28(4): 512-515 Doi:10.1002/ana.410280407 DOI: https://doi.org/10.1002/ana.410280407
Tsui JC, Jon Stoessl A, Eisen A, Calne S and Calne D. Double-Blind Study of Botulinum Toxin in Spasmodic Torticollis. The Lancet 1986; 328(8501): 245-247 Doi:10.1016/s0140-6736(86)92070-2 DOI: https://doi.org/10.1016/S0140-6736(86)92070-2
Matak, Bölcskei, Bach R and Helyes. Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins 2019; 11(8): Doi:10.3390/toxins11080459 DOI: https://doi.org/10.3390/toxins11080459
Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, . . . Decker WW. Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology 2006; 117(2): 391-397 Doi:10.1016/j.jaci.2005.12.1303 DOI: https://doi.org/10.1016/j.jaci.2005.12.1303
Rodrigues FB, Duarte GS, Marques RE, Castelão M, Ferreira J, Sampaio C, . . . Costa J. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews 2020; 2020(11): Doi:10.1002/14651858.CD003633.pub4 DOI: https://doi.org/10.1002/14651858.CD003633.pub4
Aggarwal A, Kaul V, Kaur G, Banas E, Sampath P and Roy AK. A new facial expression to botox! The American Journal of Emergency Medicine 2014; 32(3): 290.e295-290.e296 Doi:10.1016/j.ajem.2013.10.017 DOI: https://doi.org/10.1016/j.ajem.2013.10.017
Moon IJ, Chang SE and Kim SD. First case of anaphylaxis after botulinum toxin type A injection. Clinical and Experimental Dermatology 2017; 42(7): 760-762 Doi:10.1111/ced.13108 DOI: https://doi.org/10.1111/ced.13108
Careta MF, Delgado L and Patriota R. Report of Allergic Reaction After Application of Botulinum Toxin. Aesthetic Surgery Journal 2015; 35(5): NP102-NP105 Doi:10.1093/asj/sju105 DOI: https://doi.org/10.1093/asj/sju105
Li M, Goldberger BA and Hopkins C. Fatal case of BOTOX-related anaphylaxis? J Forensic Sci 2005; 50(1): 169-172 DOI: https://doi.org/10.1520/JFS2004196
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2023 Joe Ghorayeb, Timithy McClellan, Kelley Crozier (Author)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
